Search research articles
Contact Us
Filters
Showing results (31-40 of 88) with videos related to
Page
of 9
Sort By:
Annals of Neurology
|
January 1, 1996
Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study
G Logroscino, K Marder, L Cote, et al.
La Clinica Terapeutica
|
February 28, 2002
[Pott disease: current diagnostic and therapeutic approaches]
O Mazza, G Logroscino, E Pola, et al.
Neurology
|
April 17, 2008
Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study
J A Driver, T Kurth, J E Buring, et al.
Annals of Neurology
|
December 16, 1998
Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus
D C Hesdorffer, G Logroscino, G Cascino, et al.
Epilepsia
|
May 13, 1998
Short-term mortality after a first episode of status epilepticus
G Logroscino, D C Hesdorffer, G Cascino, et al.
Epilepsia
|
September 14, 2001
Time trends in incidence, mortality, and case-fatality after first episode of status epilepticus
G Logroscino, D C Hesdorffer, G Cascino, et al.
Current Medicinal Chemistry
|
July 30, 2010
Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia?
S Zoccolella, S V Lamberti, G Iliceto, et al.
Neurology
|
April 1, 1998
Incidence of status epilepticus in Rochester, Minnesota, 1965-1984
D C Hesdorffer, G Logroscino, G Cascino, et al.
Rivista Di Neurologia
|
May 1, 1987
Cerebrospinal fluid (CSF) parameters and clinical course of multiple sclerosis
P Livrea, I L Simone, M Trojano, et al.
Orthopaedics & Traumatology, Surgery & Research : OTSR
|
April 17, 2016
Fibular nerve palsy after hip replacement: Not only surgeon responsibility. Hereditary neuropathy with liability to pressure palsies (HNPP) a rare cause of nerve liability
G Logroscino, F Del Tedesco, C Cambise, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 88) with videos related to
Sort By:
Page
of 9
Annals of Neurology
|
January 1, 1996
Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study
G Logroscino, K Marder, L Cote, et al.
La Clinica Terapeutica
|
February 28, 2002
[Pott disease: current diagnostic and therapeutic approaches]
O Mazza, G Logroscino, E Pola, et al.
Neurology
|
April 17, 2008
Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study
J A Driver, T Kurth, J E Buring, et al.
Annals of Neurology
|
December 16, 1998
Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus
D C Hesdorffer, G Logroscino, G Cascino, et al.
Epilepsia
|
May 13, 1998
Short-term mortality after a first episode of status epilepticus
G Logroscino, D C Hesdorffer, G Cascino, et al.
Epilepsia
|
September 14, 2001
Time trends in incidence, mortality, and case-fatality after first episode of status epilepticus
G Logroscino, D C Hesdorffer, G Cascino, et al.
Current Medicinal Chemistry
|
July 30, 2010
Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia?
S Zoccolella, S V Lamberti, G Iliceto, et al.
Neurology
|
April 1, 1998
Incidence of status epilepticus in Rochester, Minnesota, 1965-1984
D C Hesdorffer, G Logroscino, G Cascino, et al.
Rivista Di Neurologia
|
May 1, 1987
Cerebrospinal fluid (CSF) parameters and clinical course of multiple sclerosis
P Livrea, I L Simone, M Trojano, et al.
Orthopaedics & Traumatology, Surgery & Research : OTSR
|
April 17, 2016
Fibular nerve palsy after hip replacement: Not only surgeon responsibility. Hereditary neuropathy with liability to pressure palsies (HNPP) a rare cause of nerve liability
G Logroscino, F Del Tedesco, C Cambise, et al.
Page
of 9